Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

SGX Welcomes Religare Health Trust To Mainboard

Date 19/10/2012

Singapore Exchange (SGX) is pleased to welcome the listing of Religare Health Trust (RHT) on the Mainboard under the stock code,”RF1U”.

RHT is the first India-based healthcare business trust listed in Singapore. Its initial portfolio comprises 11 clinical establishments, four clinical establishments to be developed and two hospitals located across India. Its investment mandate is to invest in medical and healthcare assets and services in Asia, Australasia and emerging markets.

Mr Ravi Mehrotra, CEO and Executive Chairman of the Trustee-Manager said: “We are delighted with the strong response the trust received from institutional investors and the public and are proud of our listing on Singapore Exchange. As the first business trust in Singapore comprising Indian healthcare assets, RHT offers investors exposure to India’s growing healthcare sector, which is benefitting from a growing economy and rising affluence. Our large and diversified portfolio of income generating assets and in-built development pipeline will provide Unitholders with a blend of stable income and upside growth potential. We also believe the expertise and experience of our Sponsor, Fortis Healthcare Limited, in managing and developing healthcare assets will be invaluable and we fully intend to leverage off that expertise and experience.”

Mr Magnus Bocker, CEO of SGX, said: “We warmly welcome RHT to the SGX family. The successful listing of Singapore’s first India-based healthcare business trust will enhance the profile of Singapore, SGX and our business trust regime amongst potential Indian issuers. We therefore look forward to more Indian companies leveraging on our Asian Gateway to access the international investor pool in Singapore for their expansion.”

The listing of Religare Health Trust reinforces our listing franchise with a strong cluster of 30 REITs and property trusts and total market capitalisation of S$50 billion (US$41 billion).